Loading...
XJPX4671
Market cap161mUSD
Jan 15, Last price  
2,364.00JPY
1D
0.94%
1Q
-4.98%
Jan 2017
60.71%
Name

Falco Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:4671 chart
P/E
15.14
P/S
0.59
EPS
156.14
Div Yield, %
4.76%
Shrs. gr., 5y
0.11%
Rev. gr., 5y
-0.53%
Revenues
43.01b
-8.33%
37,461,000,000057,027,000,00060,828,000,00062,758,000,00058,401,000,00046,593,000,00048,727,000,00045,971,000,00045,962,000,00044,156,000,00043,185,000,00043,608,000,00050,007,000,00046,913,000,00043,007,000,000
Net income
1.67b
-26.32%
115,000,0000950,000,000683,000,0001,290,000,0002,278,000,0001,117,000,0001,347,000,0001,478,000,0001,697,000,000653,000,0001,243,000,0001,853,000,0003,533,000,0002,261,000,0001,666,000,000
CFO
3.43b
+64.57%
2,294,000,0003,292,000,0002,362,000,0004,124,000,0005,431,000,000375,000,0001,054,000,0002,009,000,0001,220,000,0002,321,000,0001,651,000,0001,901,000,0002,937,000,0004,129,000,0002,086,000,0003,433,000,000
Dividend
Mar 28, 20250 JPY/sh

Profile

FALCO HOLDINGS Co., Ltd., a medical service company, primarily provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. It offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, microbiology, and radio immunoassay; genetic testing services; and genomic-based drug discovery and biotechnology drug development services. The company also provides medical information technology services; food sanitation and environmental testing services; and food related genetic testing services to food manufacturers, retailers, and restaurants. In addition, it is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical information systems, including @home Dr. electronic medical charts for clinics with concentrated clinical testing, as well as TASCAL for ASP, a medical support system. The company was founded in 1962 and is headquartered in Kyoto, Japan.
URL
http://www.falco-hd.co.jp/
IPO date
Apr 01, 1997
Employees
1,159
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
43,007,000
-8.33%
46,913,000
-6.19%
50,007,000
14.67%
Cost of revenue
30,877,000
33,068,000
33,635,000
Unusual Expense (Income)
NOPBT
12,130,000
13,845,000
16,372,000
NOPBT Margin
28.20%
29.51%
32.74%
Operating Taxes
905,000
1,433,000
2,034,000
Tax Rate
7.46%
10.35%
12.42%
NOPAT
11,225,000
12,412,000
14,338,000
Net income
1,666,000
-26.32%
2,261,000
-36.00%
3,533,000
90.66%
Dividends
(1,201,000)
(713,000)
(608,000)
Dividend yield
4.65%
3.43%
2.89%
Proceeds from repurchase of equity
(1,200,000)
1,546,000
108,000
BB yield
4.65%
-7.44%
-0.51%
Debt
Debt current
669,000
2,607,000
1,277,000
Long-term debt
465,000
655,000
3,504,000
Deferred revenue
1,983,000
Other long-term liabilities
2,170,000
341,000
2,391,000
Net debt
(12,547,000)
(11,959,000)
(9,663,000)
Cash flow
Cash from operating activities
3,433,000
2,086,000
4,129,000
CAPEX
(1,100,000)
(1,378,000)
(2,194,000)
Cash from investing activities
(1,445,000)
322,000
(2,690,000)
Cash from financing activities
(4,527,000)
(448,000)
(2,414,000)
FCF
11,626,000
11,115,000
12,648,000
Balance
Cash
10,065,000
12,603,000
10,643,000
Long term investments
3,616,000
2,618,000
3,801,000
Excess cash
11,530,650
12,875,350
11,943,650
Stockholders' equity
23,538,000
23,013,000
21,432,000
Invested Capital
17,480,350
18,657,650
16,266,350
ROIC
62.12%
71.08%
93.02%
ROCE
41.36%
43.60%
57.61%
EV
Common stock shares outstanding
11,047
10,568
10,486
Price
2,338.00
18.92%
1,966.00
-2.04%
2,007.00
14.75%
Market cap
25,828,127
24.31%
20,776,568
-1.28%
21,045,785
15.25%
EV
13,281,127
8,817,568
11,382,785
EBITDA
13,108,000
14,886,000
17,330,000
EV/EBITDA
1.01
0.59
0.66
Interest
8,000
19,000
27,000
Interest/NOPBT
0.07%
0.14%
0.16%